The support of human genetic evidence for approved drug indications
Matthew R. Nelson(Deerfield (United States)), Philippe Sanséau(GlaxoSmithKline (United Kingdom)), John C. Whittaker(University of Cambridge), Hannah Tipney, Aris Floratos(Columbia University), Paola Nicoletti(University of Florence), Yufeng Shen(Columbia University Irving Medical Center), Judong Shen(Research Triangle Park Foundation), Junwen Wang(National Institutes of Health), Mulin Jun Li(Tianjin Medical University), Jeffery L. Painter(Research Triangle Park Foundation), Lon R. Cardon(Jackson Laboratory), Pak C. Sham(University of Hong Kong)
Cited by 1,787
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Drug repurposing: progress, challenges and recommendations
|Nature Reviews Drug Discovery|2018|4.6k
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
|Nature Reviews Genetics|2008|3k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k